METABOLON CLOSES ON $5.3M IN SERIES C FUNDING
BIOMARKERS OF PROSTATE CANCER PROGRESSION IDENTIFIED
METABOLON TECHNOLOGY APPLIED TO NOVEL TOXICOLOGY RESEARCH
PLANT BIOLOGY 2009
July 18-22
WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY & BIOPROCESSING
July 19-22
Metabolon is a diagnostic products and services company offering the industry's leading biochemical profiling platform. Our patented platform provides a global analysis of complex biological samples for the discovery of markers and pathways associated with drug action and disease. This differentiated approach enables the identification of biomarkers useful for the development of a wide range of diagnostics and provides insight into complex biochemical processes such as drug action, toxicology and bioprocess optimization.